Market Overview

Delcath Announces First CHEMOSAT Procedures in Germany

Delcath Systems, Inc., (NASDAQ: DCTH) announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT® Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.

Two patients were treated for inoperable, liver-dominant metastases, one from cutaneous melanoma and one from breast cancer. The treating physicians reported that both patients were treated successfully without procedure-related complications.

Posted-In: News FDA Global

 

Related Articles (DCTH)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional